467 related articles for article (PubMed ID: 27253418)
1. Subcutaneous versus sublingual immunotherapy.
Lin CH; Alandijani S; Lockey RF
Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
[No Abstract] [Full Text] [Related]
2. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
Wolthers OD; Høst A; Frederiksen B; Halken S
Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination with allergens in children].
Demoly P; Dhivert-Donnadieu H; Bousquet J
Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation using carbamylated monomeric tree pollen drops is well tolerated in patients with allergic rhinoconjunctivitis and points towards clinical effects.
Raskopf E; Allekotte S; Compalati E; Singh J; Acikel CH; Mösges R
Allergy; 2019 Nov; 74(11):2273-2276. PubMed ID: 31106436
[No Abstract] [Full Text] [Related]
5. [Allergen specific immunotherapy: new approaches].
Tay F; Kündig TM; Senti G
Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review.
Röder E; Berger MY; de Groot H; van Wijk RG
Pediatr Allergy Immunol; 2008 May; 19(3):197-207. PubMed ID: 18221463
[TBL] [Abstract][Full Text] [Related]
7. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
Pfaar O; Hörmann K; Klimek L
MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
[TBL] [Abstract][Full Text] [Related]
8. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
Fuchs T; Klimek L
HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
[No Abstract] [Full Text] [Related]
9. [Cluster immunotherapy in allergic rhinoconjunctivitis].
Klimek L; Pfaar O
MMW Fortschr Med; 2011 Feb; 153(7):34-6. PubMed ID: 21648138
[No Abstract] [Full Text] [Related]
10. Usefulness of sublingual immunotherapy in children.
Bufe A
Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
[No Abstract] [Full Text] [Related]
11. [Allergic rhinoconjunctivitis and immunotherapy: an update].
Leimgruber A; Spertini F
Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
[TBL] [Abstract][Full Text] [Related]
12. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
Cook PR
Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
[TBL] [Abstract][Full Text] [Related]
13. The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
Adamic K; Zidarn M; Bajrovic N; Erzen R; Kopac P; Music E
Wien Klin Wochenschr; 2009; 121(9-10):357-60. PubMed ID: 19562302
[TBL] [Abstract][Full Text] [Related]
14. Meta-analyses of specific immunotherapy trials.
Calderon MA
Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
[No Abstract] [Full Text] [Related]
15. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
16. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
Cochard MM; Eigenmann PA
J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
